Teva Pharmaceutical Industries (TEVA) Shares Outstanding (Diluted) (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.76 Bn | 39.10 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 833.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.52 Bn | 5.39 Bn | 334.51 Mn | 328.10 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 545.13 Mn | 2.10 Bn | 378.10 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 291.34 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.92 Mn |
| 8 | Amphastar Pharmaceuticals | 992.46 Mn | 702.34 Mn | 93.47 Mn | 44.23 Mn |
| 9 | Fennec Pharmaceuticals | 409.53 Mn | 368.28 Mn | 17.15 Mn | 36.43 Mn |
| 10 | RedHill Biopharma | 179.80 Mn | 179.80 Mn | - | 3.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 1.16 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 1.11 Bn |